Page last updated: 2024-08-24

capecitabine and Cholangiitis, Sclerosing

capecitabine has been researched along with Cholangiitis, Sclerosing in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, M; Hwang, SY; Lawrence, TS; Sonnenday, CJ; Volk, ML; Wan, S; Welling, TH; Zalupski, MM1

Other Studies

1 other study(ies) available for capecitabine and Cholangiitis, Sclerosing

ArticleYear
Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:1

    Topics: Aged; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Cholangiocarcinoma; Cholangitis, Sclerosing; Deoxycytidine; Female; Fibrosis; Fluorouracil; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Necrosis; Neoadjuvant Therapy; Radiosurgery; Retrospective Studies; Treatment Outcome

2014